Skip to main content
Top
Published in: Supportive Care in Cancer 3/2012

01-03-2012 | Original Article

Reconceptualising relocation for specialist treatment: insights from New Zealand

Authors: Pam McGrath, Hamish Holewa

Published in: Supportive Care in Cancer | Issue 3/2012

Login to get access

Abstract

Purpose

To date, the research on relocation has been conducted in countries such as Australia where there are vast distances that need to be travelled by regional, rural and remote patients to access specialist metropolitan treatment. This research considers the issue of relocation for specialist treatment in a New Zealand context.

Methods

The exploration of the experience of relocation from the consumers’ perspective was conducted through an iterative, qualitative research methodology using open-ended interviews conducted by speaker-phone at the time and location of each participant’s choice.

Results

The three factors that underpin the phenomenon of ‘travel-based’ accommodation in New Zealand are the strong desire to return home, the small geographical distances that make this possible for many and the strong determination to endure hardship associated with travel when distances are long.

Conclusions

Any understanding of relocation for specialist treatment needs to be informed by two concepts: ‘travel-based’ relocation and ‘accommodation-based’ relocation.

Relevance of manuscript to inform research, policies and/or programs

The focus needs to be on providing supportive travel arrangements where possible. In New Zealand, as elsewhere, cancer supportive care organisations are increasingly providing volunteers to assist with travel. Such practical volunteer assistance is important, as is financial support through government subsidies to cover the cost of such travel. The insights from the study affirm the importance of health professionals who are supportive and creative in their efforts to assist people to return home. Supportive clinical care such as addressing issues in relation to nausea and pain management for those travelling must also be considered.
Literature
1.
go back to reference De la Morena M, Gatti R (2010) A history of bone marrow transplantation. Immunol Allergy Clin North Am 30(1):1–15PubMedCrossRef De la Morena M, Gatti R (2010) A history of bone marrow transplantation. Immunol Allergy Clin North Am 30(1):1–15PubMedCrossRef
2.
go back to reference Nicholson L, Sheldon-Collins G, Sih K (2009) Bone marrow transplantation at the Royal Hobart Hospital. Aust Nurs J 16(11):49PubMed Nicholson L, Sheldon-Collins G, Sih K (2009) Bone marrow transplantation at the Royal Hobart Hospital. Aust Nurs J 16(11):49PubMed
3.
go back to reference National Rural Health Alliance (NRHA) (2007) Submission to Australian Senate Community Affairs Committee inquiry on patient assisted travel schemes. Senate Printing Unit, Parliament House, Canberra National Rural Health Alliance (NRHA) (2007) Submission to Australian Senate Community Affairs Committee inquiry on patient assisted travel schemes. Senate Printing Unit, Parliament House, Canberra
4.
go back to reference Standing Committee on Community Affairs (SCCA) (2007) Highway to health: better access for rural, regional and remote patients. Senate Committee Report. Senate Printing Unit, Parliament House, Canberra Standing Committee on Community Affairs (SCCA) (2007) Highway to health: better access for rural, regional and remote patients. Senate Committee Report. Senate Printing Unit, Parliament House, Canberra
5.
go back to reference Ho S, Horne D, Szer J (2002) The adaptation of patients during the hospitalization period of bone marrow transplantation. J Clin Psychol Med Settings 9:167–175CrossRef Ho S, Horne D, Szer J (2002) The adaptation of patients during the hospitalization period of bone marrow transplantation. J Clin Psychol Med Settings 9:167–175CrossRef
6.
go back to reference Mah K, Khoraych M, Lipton J, Messner H, Khoraych G, Krawiec K, Lefebvre F, Devins G (2008) Do allogeneic bone marrow transplant candidates match coping to controllability of pre-treatment stressors? Psychol Health Med 13(3):337–345PubMedCrossRef Mah K, Khoraych M, Lipton J, Messner H, Khoraych G, Krawiec K, Lefebvre F, Devins G (2008) Do allogeneic bone marrow transplant candidates match coping to controllability of pre-treatment stressors? Psychol Health Med 13(3):337–345PubMedCrossRef
7.
go back to reference Schulz-Kindermann F, Hennings U, Ramm G, Zander A, Hasenbring M (2002) The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marrow Transplant 29:341–351PubMedCrossRef Schulz-Kindermann F, Hennings U, Ramm G, Zander A, Hasenbring M (2002) The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marrow Transplant 29:341–351PubMedCrossRef
8.
go back to reference Hochhausen N, Papadopolous E, Altmaier E, Carter S, McQuellon R, Henslee-Downey J, Davies S (2007) Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. J Psychosoc Oncol 25(1):87–100PubMedCrossRef Hochhausen N, Papadopolous E, Altmaier E, Carter S, McQuellon R, Henslee-Downey J, Davies S (2007) Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. J Psychosoc Oncol 25(1):87–100PubMedCrossRef
9.
go back to reference McGrath P (1999) Experience of relocation for specialist treatment for haematological malignancies. Cancer Strategy 1:157–163 McGrath P (1999) Experience of relocation for specialist treatment for haematological malignancies. Cancer Strategy 1:157–163
10.
go back to reference McGrath P, Rogers T (2003) Relocation for specialist treatment for paediatric acute lymphoblastic leukaemia. Austral-Asian J Cancer 2(2):107–115 McGrath P, Rogers T (2003) Relocation for specialist treatment for paediatric acute lymphoblastic leukaemia. Austral-Asian J Cancer 2(2):107–115
11.
go back to reference McGrath P (1998) Relocation for treatment for leukaemia: a description of need. Aust Health Rev 21(4):143–154PubMedCrossRef McGrath P (1998) Relocation for treatment for leukaemia: a description of need. Aust Health Rev 21(4):143–154PubMedCrossRef
12.
go back to reference McGrath P (1999) Accommodation for patients and carers during relocation for treatment for leukaemia: a descriptive profile. Support Care Cancer 7:6–10PubMedCrossRef McGrath P (1999) Accommodation for patients and carers during relocation for treatment for leukaemia: a descriptive profile. Support Care Cancer 7:6–10PubMedCrossRef
13.
go back to reference Holloway I (2008) A–Z of qualitative research in healthcare, 2nd edn. Blackwell, Oxford Holloway I (2008) A–Z of qualitative research in healthcare, 2nd edn. Blackwell, Oxford
14.
go back to reference Patton M (2002) Qualitative research and evaluation methods, 3rd edn. Sage, Thousand Oaks Patton M (2002) Qualitative research and evaluation methods, 3rd edn. Sage, Thousand Oaks
15.
go back to reference Krathwohl D (1993) Methods of educational and social science research: an integrated approach. Longman, New York Krathwohl D (1993) Methods of educational and social science research: an integrated approach. Longman, New York
16.
go back to reference Polit D, Hungler B (1995) Nursing research: principles and methods, 5th edn. Lippincott, Philadelphia Polit D, Hungler B (1995) Nursing research: principles and methods, 5th edn. Lippincott, Philadelphia
17.
go back to reference Gaskill D, Henderson A, Fraser M (1997) Exploring the everyday world of the patient in isolation. Oncol Nurs Forum 24(4):695–700PubMed Gaskill D, Henderson A, Fraser M (1997) Exploring the everyday world of the patient in isolation. Oncol Nurs Forum 24(4):695–700PubMed
18.
go back to reference McGrath P (2001) Returning home after specialist treatment for haematological malignancies: an Australian study. Fam Community Health 24:36–48PubMed McGrath P (2001) Returning home after specialist treatment for haematological malignancies: an Australian study. Fam Community Health 24:36–48PubMed
Metadata
Title
Reconceptualising relocation for specialist treatment: insights from New Zealand
Authors
Pam McGrath
Hamish Holewa
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1102-3

Other articles of this Issue 3/2012

Supportive Care in Cancer 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine